Ganli Pharmaceutical Industry: Net profit increased by 101.96% year-on-year in the first half of 2025.

Ganli Pharmaceuticals announced that its operating income in the first half of 2025 was 20.67 billion yuan, a year-on-year increase of 57.18%. Net profit was 6.04 billion yuan, a year-on-year increase of 101.96%.